Jonathan Aschoff, Ph.D.
Managing Director, Senior Research AnalystContact
Jonathan Aschoff, Ph.D. is a Managing Director, Senior Research Analyst Roth Capital Partners covering the biotechnology sector. Dr. Aschoff has over 20 years of sell-side analyst experience, almost entirely in the biotechnology sector, and tends to focus his coverage on small and microcap companies. From 2005 to 2014, Dr. Aschoff has earned several awards in the biotechnology or pharmaceutical sector based on investment return - from organizations such as The Wall Street Journal, Financial Times, Forbes, Starmine, and Tipranks. Dr. Aschoff earned a bachelor's degree in Biology from Tufts University and a Ph.D. in Microbiology and Molecular Biology from Tufts University School of Medicine. His Ph.D. thesis involved determining the function of the 3' untranslated region of avian retroviral genomic mRNA.
Tufts University & Tufts University School of Medicin
Sturzas's Institutional Research, Dain Rauscher Wessels, Friedman Billings Ramsey, Maxim, Brean Capital, National Securitie
Biotechnology No. 3 Master Stock Picker “Best on the Street” Award The Wall Street Journal 2005
Pharmaceuticals No. 1 Master Stock Picker “Best on the Street” Award The Wall Street Journal 2005
Biotechnology No. 1 Stock Picker “Best Brokerage Analysts” Award, Forbes StarMine 2007
Biotechnology No. 2 Master Stock Picker “Best on the Street” Award The Wall Street Journal 2008
Biotechnology No. 2 Stock Picker Analyst Award, FT StarMine 2011
Named as TipRanks No. 1 Analyst across all sector for 2014 No. 1 Analyst across all sector for 2014 TipRanks